Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 3
1999 6
2000 8
2001 7
2002 8
2003 6
2004 2
2005 5
2006 5
2007 9
2008 1
2009 2
2010 5
2011 3
2012 4
2013 3
2014 3
2015 1
2016 3
2017 2
2018 2
2019 4
2020 2
2021 1
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

92 results
Results by year
Filters applied: . Clear all
Page 1
Antineonatal Fc Receptor Antibody Treatment Ameliorates MOG-IgG-Associated Experimental Autoimmune Encephalomyelitis.
Remlinger J, Madarasz A, Guse K, Hoepner R, Bagnoud M, Meli I, Feil M, Abegg M, Linington C, Shock A, Boroojerdi B, Kiessling P, Smith B, Enzmann V, Chan A, Salmen A. Remlinger J, et al. Among authors: boroojerdi b. Neurol Neuroimmunol Neuroinflamm. 2022 Jan 13;9(2):e1134. doi: 10.1212/NXI.0000000000001134. Print 2022 Mar. Neurol Neuroimmunol Neuroinflamm. 2022. PMID: 35027475 Free PMC article.
Pharmacologic influences on TMS effects.
Boroojerdi B. Boroojerdi B. J Clin Neurophysiol. 2002 Aug;19(4):255-71. doi: 10.1097/00004691-200208000-00002. J Clin Neurophysiol. 2002. PMID: 12436084 Review.
Mechanisms underlying human motor system plasticity.
Boroojerdi B, Ziemann U, Chen R, Bütefisch CM, Cohen LG. Boroojerdi B, et al. Muscle Nerve. 2001 May;24(5):602-13. doi: 10.1002/mus.1045. Muscle Nerve. 2001. PMID: 11317269 Review.
Precompetitive Consensus Building to Facilitate the Use of Digital Health Technologies to Support Parkinson Disease Drug Development through Regulatory Science.
Stephenson D, Alexander R, Aggarwal V, Badawy R, Bain L, Bhatnagar R, Bloem BR, Boroojerdi B, Burton J, Cedarbaum JM, Cosman J, Dexter DT, Dockendorf M, Dorsey ER, Dowling AV, Evers LJW, Fisher K, Frasier M, Garcia-Gancedo L, Goldsack JC, Hill D, Hitchcock J, Hu MT, Lawton MP, Lee SJ, Lindemann M, Marek K, Mehrotra N, Meinders MJ, Minchik M, Oliva L, Romero K, Roussos G, Rubens R, Sadar S, Scheeren J, Sengoku E, Simuni T, Stebbins G, Taylor KI, Yang B, Zach N. Stephenson D, et al. Among authors: boroojerdi b. Digit Biomark. 2020 Nov 26;4(Suppl 1):28-49. doi: 10.1159/000512500. eCollection 2020 Winter. Digit Biomark. 2020. PMID: 33442579 Free PMC article. Review.
A Disease Progression Model to Quantify the Nonmotor Symptoms of Parkinson's Disease in Participants With Leucine-Rich Repeat Kinase 2 Mutation.
Ahamadi M, Mehrotra N, Hanan N, Lai Yee K, Gheyas F, Anton J, Bani M, Boroojerdi B, Smit H, Weidemann J, Macha S, Thuillier V, Chen C, Yang M, Williams-Gray CH, Stebbins GT, Pagano G, Hang Y, Marek K, Venuto CS, Javidnia M, Dexter D, Pedata A, Stafford B, Akalu M, Stephenson D, Romero K, Sinha V; Critical Path for Parkinson’s Consortium. Ahamadi M, et al. Among authors: boroojerdi b. Clin Pharmacol Ther. 2021 Aug;110(2):508-518. doi: 10.1002/cpt.2277. Epub 2021 Jun 12. Clin Pharmacol Ther. 2021. PMID: 33894056
Cholinergic influences on use-dependent plasticity.
Sawaki L, Boroojerdi B, Kaelin-Lang A, Burstein AH, Bütefisch CM, Kopylev L, Davis B, Cohen LG. Sawaki L, et al. Among authors: boroojerdi b. J Neurophysiol. 2002 Jan;87(1):166-71. doi: 10.1152/jn.00279.2001. J Neurophysiol. 2002. PMID: 11784739 Free article. Clinical Trial.
92 results